Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher N Andrews

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
IEEE Transactions on Biomedical Circuits and Systems|June 3, 2017
Wearable Microsystem for Minimally Invasive, Pseudo-Continuous Blood Glucose Monitoring: The e-MosquitoGang Wang, Michael D Poscente, Simon S Park, et al.
Neurogastroenterology and Motility|August 4, 2020
Prucalopride in diabetic and connective tissue disease-related gastroparesis: Randomized placebo-controlled crossover pilot trialChristopher N Andrews, Matthew Woo, Michelle Buresi, et al.
Canadian Journal of Gastroenterology & Hepatology|March 9, 2017
Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic AgentsYvonne Tse, David Armstrong, Christopher N Andrews, et al.
The American Journal of Gastroenterology|August 2, 2017
Corrigendum: ACG and CAG Clinical Guideline: Management of DyspepsiaPaul M Moayyedi, Brian E Lacy, Christopher N Andrews, et al.
Scandinavian Journal of Gastroenterology|December 13, 2005
Simple clinical variables predict liver histology in hepatitis C: prospective validation of a clinical prediction modelJoseph Romagnuolo, Christopher N Andrews, Vincent G Bain, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 31, 2025
Glucagon-like Peptide-1 Agonist Liraglutide Induces Temporary Impairment to Gastric Electrical Activity in Healthy VolunteersSchynell Coutinho, Chris Varghese, Eric Buenz, et al.
Biomedical Engineering Online|June 27, 2022
In vivo experimental validation of detection of gastric slow waves using a flexible multichannel electrogastrography sensor linear arrayAtchariya Sukasem, Stefan Calder, Timothy R Angeli-Gordon, et al.
Neurogastroenterology and Motility|June 14, 2021
Manometric parameters, when measured with the 3-dimensional high-definition anorectal manometry probe, poorly predict prolonged balloon expulsion timeMatthew Woo, Armaan Pandey, Harman Gill, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic DisordersChristopher N Andrews, Shane M Devlin, Bernard Le Foll, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 4, 2008
Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humansAdil E Bharucha, Nisha Charkoudian, Christopher N Andrews, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
IEEE Transactions on Biomedical Circuits and Systems|June 3, 2017
Wearable Microsystem for Minimally Invasive, Pseudo-Continuous Blood Glucose Monitoring: The e-MosquitoGang Wang, Michael D Poscente, Simon S Park, et al.
Neurogastroenterology and Motility|August 4, 2020
Prucalopride in diabetic and connective tissue disease-related gastroparesis: Randomized placebo-controlled crossover pilot trialChristopher N Andrews, Matthew Woo, Michelle Buresi, et al.
Canadian Journal of Gastroenterology & Hepatology|March 9, 2017
Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic AgentsYvonne Tse, David Armstrong, Christopher N Andrews, et al.
The American Journal of Gastroenterology|August 2, 2017
Corrigendum: ACG and CAG Clinical Guideline: Management of DyspepsiaPaul M Moayyedi, Brian E Lacy, Christopher N Andrews, et al.
Scandinavian Journal of Gastroenterology|December 13, 2005
Simple clinical variables predict liver histology in hepatitis C: prospective validation of a clinical prediction modelJoseph Romagnuolo, Christopher N Andrews, Vincent G Bain, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 31, 2025
Glucagon-like Peptide-1 Agonist Liraglutide Induces Temporary Impairment to Gastric Electrical Activity in Healthy VolunteersSchynell Coutinho, Chris Varghese, Eric Buenz, et al.
Biomedical Engineering Online|June 27, 2022
In vivo experimental validation of detection of gastric slow waves using a flexible multichannel electrogastrography sensor linear arrayAtchariya Sukasem, Stefan Calder, Timothy R Angeli-Gordon, et al.
Neurogastroenterology and Motility|June 14, 2021
Manometric parameters, when measured with the 3-dimensional high-definition anorectal manometry probe, poorly predict prolonged balloon expulsion timeMatthew Woo, Armaan Pandey, Harman Gill, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic DisordersChristopher N Andrews, Shane M Devlin, Bernard Le Foll, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 4, 2008
Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humansAdil E Bharucha, Nisha Charkoudian, Christopher N Andrews, et al.
Pageof 14